"Serum Amyloid A Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.
| Descriptor ID |
D000685
|
| MeSH Number(s) |
D12.776.049.407.750 D12.776.124.050.725
|
| Concept/Terms |
Serum Amyloid A Protein- Serum Amyloid A Protein
- Amyloid A Protein-Related Serum Component
- Amyloid A Protein Related Serum Component
- Amyloid Protein AA Precursor
- Serum Amyloid Protein A
- Amyloid Serum Protein SAA
- Amyloid-Related Serum Protein (SAA)
- Serum A Related Protein
- Serum Amyloid A
- Amyloid A Precursor
- Amyloid Protein SAA
|
Below are MeSH descriptors whose meaning is more general than "Serum Amyloid A Protein".
Below are MeSH descriptors whose meaning is more specific than "Serum Amyloid A Protein".
This graph shows the total number of publications written about "Serum Amyloid A Protein" by people in this website by year, and whether "Serum Amyloid A Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 2 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 4 | 1 | 5 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serum Amyloid A Protein" by people in Profiles.
-
Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formation. Atherosclerosis. 2024 04; 391:117492.
-
Deficiency of Acute-Phase Serum Amyloid A Exacerbates Sepsis-Induced Mortality and Lung Injury in Mice. Int J Mol Sci. 2023 Dec 15; 24(24).
-
Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein. J Lipid Res. 2023 05; 64(5):100365.
-
Evaluation of serum concentration of acute-phase proteins (haptoglobin and serum amyloid A) in the affected Arabian foals with rhodococcosis. Vet Med Sci. 2023 Jan; 9(1):144-149.
-
Serum Amyloid A is not obligatory for high-fat, high-sucrose, cholesterol-fed diet-induced obesity and its metabolic and inflammatory complications. PLoS One. 2022; 17(4):e0266688.
-
Adipocyte-Derived Serum Amyloid A Promotes Angiotensin II-Induced Abdominal Aortic Aneurysms in Obese C57BL/6J Mice. Arterioscler Thromb Vasc Biol. 2022 05; 42(5):632-643.
-
High-Density Lipoproteins and Serum Amyloid A (SAA). Curr Atheroscler Rep. 2021 01 15; 23(2):7.
-
Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis. J Biol Chem. 2021 Jan-Jun; 296:100120.
-
Serum amyloid A is not incorporated into HDL during HDL biogenesis. J Lipid Res. 2020 03; 61(3):328-337.
-
Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019 03; 567(7747):249-252.